Holly Miller
Family · Fresno, CANPI 1609286749
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 347 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 26 manufacturers reported payments, led by AbbVie at 35.9% of the total. Among family clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 347 payments — averaging $17.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$518
- E.r. Squibb & Sons, L.L.C.$435
- Incyte Corporation$388
- Novartis$310
- LEO Pharma Inc.$262
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,94796%
- Education$2754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 133 | $2,236 |
| Johnson & Johnson | 37 | $518 |
| E.r. Squibb & Sons, L.L.C. | 23 | $435 |
| Incyte Corporation | 19 | $388 |
| Novartis | 16 | $310 |
| LEO Pharma Inc. | 14 | $262 |
| Regeneron Healthcare Solutions, Inc. | 9 | $230 |
| Lilly USA, LLC | 17 | $224 |
| Sun Pharmaceutical Industries Inc. | 6 | $210 |
| UCB, Inc. | 8 | $180 |
| Amgen | 8 | $164 |
| Arcutis Biotherapeutics, Inc. | 10 | $156 |
| VYNE Pharmaceuticals Inc. | 5 | $127 |
| Galderma Laboratories, L.p. | 7 | $110 |
| Sanofi | 4 | $92 |
| Pfizer | 5 | $92 |
| Boehringer Ingelheim | 3 | $87 |
| Dermavant Sciences, Inc. | 4 | $82 |
| Janssen Scientific Affairs, LLC | 2 | $80 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $74 |
| Botanix SB Inc | 3 | $58 |
| Verrica Pharmaceuticals Inc. | 2 | $36 |
| Biofrontera Inc. | 1 | $21 |
| Organon | 5 | $20 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $15 |
How this compares
$6,222 in reported general payments places this provider in the 95th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 35 | $130,526 |
| Clobetasol Propionate | 159 | $6,551 |
| Fluorouracil | 84 | $5,017 |
| Ketoconazole | 172 | $2,440 |
| Metronidazole | 44 | $1,936 |
| Clindamycin Phosphate | 59 | $1,737 |
| Doxycycline Hyclate | 46 | $1,564 |
| Dapsone | 17 | $1,410 |
| Imiquimod | 21 | $747 |
| Hydroxychloroquine Sulfate | 14 | $663 |
| Triamcinolone Acetonide | 56 | $603 |
| Cephalexin | 11 | $473 |
| Gabapentin | 27 | $362 |
| Hydrocortisone | 29 | $175 |
| ValacyclovirValacyclovir Hcl | 14 | $132 |
Paid to pharmacies, not to this prescriber.
Other family in Fresno
- Freddy EspinozaFresno$33K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.